Search Our Scientific Publications & Authors

Br J Surg 2019 Feb 18. Epub 2019 Feb 18.

Department of Molecular Medicine and Surgery, Karolinska Institutet and Center of Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden.

Background: Population-based studies of treatment of locally recurrent rectal cancer (LRRC) are lacking. The aim was to investigate the surgical treatment of patients with LRRC at a national population-based level.

Methods: All patients undergoing abdominal resection for primary rectal cancer between 1995 and 2002 in Sweden with LRRC as a first event were included. Read More

J Investig Med High Impact Case Rep 2019 Jan-Dec;7:2324709619828408

1 Brookdale University Hospitals and Medical Center, New York, NY, USA.

Female urethral diverticular cancer is a very rare entity with only around 100 cases reported so far in literature and accounts for <1% of all malignancies. In this article, we present a 47-year-old African American female with repeated hospital visits for urinary retention, hematuria, and urinary tract infections. Initial computed tomography imaging and cystoscopy was unremarkable except for a distended urinary bladder. Read More

Colorectal Dis 2019 Feb 6. Epub 2019 Feb 6.

Department of Digestive Surgery, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

We read with great interest the article by Lee et al. on the prevention of empty pelvic syndrome, a major clinical problem after total pelvic exenteration (1). Different methods for closure of large wounds have been proposed, with each technique showing its associated advantages and disadvantages. Read More

Colorectal Dis 2019 Feb 6. Epub 2019 Feb 6.

Surgical Outcomes Research Centre (SOuRCe), School of Public Health, University of Sydney, Sydney, New South Wales, Australia.

Pelvic exenteration surgery for recurrence rectal cancer is especially challenging compared to locally advanced primary rectal cancer due to fibrosis, pelvic sepsis secondary to anastomotic leak, radiotherapy and the change in anatomical planes due to previous rectal dissection. The healing of the pelvic floor and skin can be also affected, especially with the empty pelvis after total exenteration. This is due to pelvic fluid accumulation, which has approximately 20-25% risk of infection from our data. Read More

Zhonghua Wei Chang Wai Ke Za Zhi 2019 Jan;22(1):59-65

Department of General Surgery, Peking University First Hosiptal, Beijing 100034,China.

Objective: To investigate the value of neoadjuvant chemoradiotherapy (nCRT) combined with total pelvic exenteration (TPE) in the treatment of primary T4b rectal cancer.

Methods: A retrospective cohort study was conducted to analyze the clinicopathological data of 31 patients with primary T4b rectal cancer who underwent TPE from January 2008 to December 2015 at Peking University First Hospital.

Inclusion Criteria: preoperative clinical stage (cTNM) was defined as cT4b primary rectal cancer with only front wall Invasion; the lower edge of tumor was within 10 cm from the anal margin; TPE was performed; R0 resection was confirmed by pathology. Read More

Gan To Kagaku Ryoho 2018 Dec;45(13):2027-2029

Dept. of Surgery, NTT West Osaka Hospital.

We report a case of advanced sigmoid colon cancer that was resected after chemoradiation therapy(CRT)following ineffective chemotherapy. A 59-year-old woman harbored a lower abdominal tumor the size of an infant's head and was diagnosed with a huge sigmoid colon cancer with invasion to the urinary bladder and metastases to the para-aortic lymph nodes. The patient received 2 courses of modified FOLFOX6(mFOLFOX6)plus cetuximab therapy, which was assessed as ineffective; She then received CRTwith 50. Read More

Gan To Kagaku Ryoho 2018 Dec;45(13):2048-2050

Dept. of Surgery, Amagasaki Chuo Hospital.

We report a case of locally advanced colon cancer that directly invaded the rectum wall and uterus resulting in huge mass in the whole pelvis that we could successfully made complete radical resection of the whole tumor without exposing the tumor to the surgical margin after the triplet chemotherapy. The patient was a 57-year-old woman complaining of anus pain, melena, fever, and weight loss. Although swelling of the regional lymph node was observed, no distant metastasis was found resulting in clinical diagnosis of Stage Ⅲb. Read More

Mol Clin Oncol 2019 Jan 26;10(1):92-96. Epub 2018 Oct 26.

Department of Obstetrics and Gynecology, Hakodate Central General Hospital, Hakodate, Hokkaido 040-8585, Japan.

The present report describes a case of laparoscopic posterior pelvic exenteration of a primary adenocarcinoma of the rectovaginal septum (PARS) without associated endometriosis. A 49-year-old woman was admitted to hospital for rectal bleeding. Imaging studies showed a 7-cm solid tumor located in the rectovaginal septum, presenting with invasion to the posterior aspect of the uterine cervix and the anterior rectal wall. Read More

Gynecol Oncol Rep 2019 Feb 21;27:46-49. Epub 2018 Dec 21.

University of Arizona, Tucson, AZ, USA.

Mucinous adenocarcinoma of the endometrium (MACE) is a rare subtype of endometrial adenocarcinoma that often presents a significant diagnostic challenge due to its variation from the conventional morphologic appearance of endometrioid epithelium. This case report is of a woman who has survived 4 years after pelvic exenteration and subsequent vulvectomy for recurrent MACE. Read More

J Minim Invasive Gynecol 2019 Jan 4. Epub 2019 Jan 4.

Department of Woman s and Child Health, Fondazione Policlinico Universitario "Agostino Gemelli", IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy (Drs. Bizzarri, Fagotti, Cappuccio, Gallotta, Scambia, and Vizzielli). Electronic address:

Study Objective: To assess the feasibility and efficacy of minimally invasive pelvic exenteration (MIPE) in a multi-institutional Italian case series of women with gynecologic cancer and a review of the literature.

Design: Retrospective cohort study (Canadian Task Force classification II-2).

Setting: Three Italian university/teaching hospitals: "Agostino Gemelli" Foundation University Hospital in Rome, "ARNAS Civico Di Cristina Benfratelli" Hospital in Palermo, and "Maggiore della Carità" Hospital in Novara. Read More

Ann Ital Chir 2018 ;89:229-236

Introduction: Although multi-organ resections (MOR) are recommended by international guidelines for advanced colorectal cancer, the literature shows that the morbidity and mortality that accompanies these complex interventions limits the number of patients receiving this treatment. The purpose of our study was to analyse the immediate and remote results obtained after MOR and to identify potential factors that might influence the outcome.

Material And Method: Our study is a retrospective cohort which included patients surgically treated in our service for locally advanced colorectal cancer. Read More

World J Gastroenterol 2018 Dec;24(45):5144-5153

Colorectal Unit, Hospital Universitario y Politecnico La Fe, University of Valencia, Valencia 46026, Spain.

Aim: To identify short-term and oncologic outcomes of pelvic exenterations (PE) for locally advanced primary rectal cancer (LAPRC) in patients included in a national prospective database.

Methods: Few studies report on PE in patients with LAPRC. For this study, we included PE for LAPRC performed between 2006 and 2017, as available, from the Rectal Cancer Registry of the Spanish Association of Surgeons [Asociación Española de Cirujanos (AEC)]. Read More

Colorectal Dis 2018 Dec 7. Epub 2018 Dec 7.

Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia.

Aim: Perineal wound complications and pelvic abscesses remain a major source of morbidity after total pelvic exenteration. The void created in the pelvis after these multi-visceral resections leads to fluid accumulation and translocation of bowel within the pelvic cavity, which may increase the risk of pelvic abscess, perineal fluid discharge with perineal wound dehiscence and prolonged ileus. This study describes a novel technique using degradable synthetic mesh with overlying omentum to preclude small bowel and fill the empty space after total pelvic exenteration, and aimed to investigate the rate of pelvic abscess and perineal wound-related complications in this group. Read More

Indian J Surg Oncol 2018 Dec 20;9(4):552-557. Epub 2018 Jul 20.

22nd Department of Surgery, Attikon Hospital, University of Athens Medical School, 1 Rimini Str, 124 10 Chaidari, Greece.

Pelvic exenteration (PE) is one of the most drastic operations in surgical oncology, associated with severe morbidity and mortality. The objective of our study was to review our experience of PE in terms of surgical characteristics, complications, and overall survival. All patients who had PE surgery between January 1999 and December 2015 were identified. Read More

Indian J Surg Oncol 2018 Dec 23;9(4):547-551. Epub 2018 Jul 23.

5Department of Biotechnology and Microbiology, Karnatak University, Dharwad, 580003 Karnataka India.

Involvement of the bladder by colorectal cancer is sufficiently rare to be encountered by an individual surgeon on an infrequent basis. Extirpative procedures for advanced colorectal cancers can involve partial/total bladder resections. In patients without evidence of distant metastatic disease, a reasonable therapeutic effect can be expected when negative surgical margins are obtained. Read More

Ann Surg Oncol 2018 Dec 5. Epub 2018 Dec 5.

Chirurgische Klinik I, Lukaskrankenhaus Neuss, Neuss, Germany.

Background: Pelvic exenteration (PE) is a complex and challenging surgical procedure. The reported results of this procedure for primary and recurrent disease are limited and conflicting.

Methods: This study analyzed patient outcomes after all PEs performed in the authors' department between October 2001 and December 2016. Read More

Ginekol Pol 2018;89(11):618-626

Clinical Department of Gynecological Oncology, Professor Franciszek Lukaszczyk Oncology Center, Bydgoszcz, Poland; Department of Oncology, Radiotherapy and Oncological Gynecology, Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.

Objectives The aim of our study has been to determine the association between the appearance of infection after modified posterior pelvic exenteration (MPE) and TTC (time to adjuvant chemotherapy) and to examine whether the infection impacts clinical results by delaying the start of chemotherapy. Material and methods The present, retrospective study analyzed 77 patients who had undergone MPE followed by adjuvant chemotherapy. Either no residual tumor or tumor less than 2. Read More

Tech Coloproctol 2018 11 1;22(11):835-845. Epub 2018 Dec 1.

Colorectal Unit, Derriford Hospital, Plymouth Hospital NHS Trust, Plymouth, UK.

Background: Pelvic exenteration represents the best treatment option for cure of locally advanced or recurrent rectal cancer. This systematic review sought to evaluate current literature regarding short and long term treatment outcomes and long term survival following pelvic exenteration.

Methods: A systematic search of the MEDLINE, PubMed and Ovid databases was conducted to identify suitable articles published between 2001 and 2016. Read More

Gynecol Oncol 2019 01 16;152(1):218-219. Epub 2018 Nov 16.

Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address:

Gynecol Oncol 2019 01 8;152(1):151-156. Epub 2018 Nov 8.

Division of Gynecologic Surgery, Mayo Clinic, Rochester, MN, USA. Electronic address:

Objective: Pelvic exenteration (PE) is an extensive surgery associated with high rates of postoperative morbidity and mortality. The absence of well-defined preoperative selection criteria to identify patients eligible for PE prompted the assessment of pre-operative predictors of 30-day major surgical complications.

Methods: Demographics and surgical characteristics of patients undergoing PE for gynecologic cancer in a single institution between 01/2004-12/2016 were reviewed. Read More

Int J Gynecol Cancer 2018 Nov;28(9):1796-1804

Lifespan Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI.

Objective: The aim of this study was to evaluate contemporary practices and opinions among gynecologic oncologists regarding the use of total pelvic exenteration (TPE) for palliative intent.

Methods: This cross-sectional study of the membership of the Society of Gynecologic Oncology utilized an electronic survey to assess the opinions and practice patterns of gynecologic oncologists regarding TPEs. The primary outcome was willingness to consider a TPE for palliative intent, and demographic and practice characteristics were collected for correlation. Read More

Int J Gynecol Cancer 2018 Nov;28(9):1805-1806

Department of Obstetrics and Gynecology, Ospedale Maggiore della Carità Università degli Studi del Piemonte Orientale, Novara, Italy.

Study Objective: The video article describes a laparoscopic anterior pelvic exenteration with radical vaginectomy using the 3-dimensional (3D) vision and multifunction instruments.

Methods: This is a step-by-step video presentation of the laparoscopic anterior pelvic exenteration (Canadian Task Force classification III). Although the therapeutic benefit of the PE remains controversial, it is often performed in women with centrally recurrent pelvic tumors that previously received radiation therapy or in the locally advanced cases (ie, stage IIb-IVa) resistant to radiochemotherapy. Read More

Tech Coloproctol 2018 09 10;22(9):663-671. Epub 2018 Oct 10.

Department of Surgery, Complex Cancer Clinic, St. Mark's Hospital, London, UK.

Background: Complete pathological resection of locally advanced and recurrent anorectal cancer is considered the most important determinant of survival outcome. Involvement of the retropubic space with cancer threatening or involving the penile base poses specific challenges due to the potential for margin involvement and blood loss from the dorsal venous plexus. In the present study we evaluate a new transperineal surgical approach to excision of anterior compartment organs involved or threatened by cancer which facilitates exposure and visualisation of the bulbar urethra and the deep vein of the penis caudal to the retropubic space and penile base. Read More

BJS Open 2018 Sep 22;2(5):328-335. Epub 2018 May 22.

Surgical Outcomes Research Centre Royal Prince Alfred Hospital Sydney New South Wales Australia.

Background: Pelvic exenteration (PE) is the preferred treatment available for selected patients diagnosed with locally advanced or recurrent cancer confined to the pelvis. Currently, the majority of the literature reports only on short-term survival and quality-of-life (QoL) outcomes. The aim of this prospective cohort study was to describe long-term survival and QoL outcomes following PE. Read More

Eur J Surg Oncol 2018 12 3;44(12):1929-1934. Epub 2018 Sep 3.

Introduction: The objective of this study was to report a 30-year experience of PE for gynecologic malignancies in a cancer center.

Materials And Methods: A retrospective study was conducted at Institut Paoli-Calmette including patients who underwent PE for gynecologic malignancies. Four periods were evaluated: P1 before 1992, P2 between 1993 and 1999, P3 between 2000 and 2006 and P4 after 2006. Read More

Am J Obstet Gynecol 2018 Dec 18;219(6):598.e1-598.e10. Epub 2018 Sep 18.

Department of Obstetrics, Gynecology, and Reproductive Sciences, Temple University Hospital, Philadelphia, PA; Division of Gynecologic Oncology, Fox Chase Cancer Center, Philadelphia, PA.

Background: Patients with ovarian cancer experience a high rate of anemia throughout their treatment course, with rates that range from 19-95%. Blood transfusions offer symptom relief but may be costly, are limited in supply, and have been associated with worse 30-day surgical morbidity and mortality rates.

Objective: The purpose of this study was to identify risk factors for blood transfusion with packed red blood cell and to develop a transfusion risk score to identify patients who undergo surgery for ovarian cancer and who are at lowest risk for a blood transfusion. Read More

Urol J 2018 Sep 11. Epub 2018 Sep 11.

Department of Surgery, Matsuyama Shimin Hospital, Ehime, Japan.

A 72-year-old Japanese man presented to the hospital with complaints of gross hematuria. Contrast enhanced computed tomography revealed a broad-based, approximately 3-cm bladder tumor near the right ureteral orifice and a 5-cm mass located between the prostate and rectum. The patient underwent transurethral resection of the bladder tumor and a transrectal biopsy of the lesion. Read More

Support Care Cancer 2018 Sep 5. Epub 2018 Sep 5.

Royal Prince Alfred Hospital, Sydney, NSW, Australia.

Purpose: Compliance with oral nutrition support (ONS) is poorly reported in the literature. Many factors influence compliance, which could mask the true benefits of preoperative ONS. Surgical oncology patients, including pelvic exenteration patients, are often requested by healthcare workers to consume nutrition supplements before surgery. Read More

Aktuelle Urol 2018 Sep 5;49(5):405-411. Epub 2018 Sep 5.

Klinik für Urologie, Uro-Onkologie, spezielle urologische und roboter-assistierte Chirurgie, Universitätsklinikum Köln, Köln.

If prostate cancer recurs after primary treatment, deprivation therapy with LHRH analogues or antagonists is the treatment of choice in men with metastatic prostate cancer. However, this treatment only achieves palliative results. Median time to progression ranges between 11 and 78 months. Read More

Gynecol Oncol 2018 10 1;151(1):178-179. Epub 2018 Sep 1.

Department of Surgical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France; INSERM, CRCT Team 19, ONCOSARC - Oncogenesis of sarcomas, Toulouse, France. Electronic address:

Urology 2018 Nov 29;121:203.e1-203.e5. Epub 2018 Aug 29.

Department of Pathology, Johns Hopkins Medical Institute, Baltimore, MD; Department of Urology, Johns Hopkins Medical Institute, Baltimore, MD; Department of Oncology, Johns Hopkins Medical Institute, Baltimore, MD. Electronic address:

Objective: To better characterize granular cell tumor of the bladder, with only 20 cases reported to date and unclear management guidelines.

Methods: We report five benign and one malignant granular cell tumor of the bladder.

Results: Patients were in the age range of 33 to 73 years. Read More

Int J Gynecol Cancer 2018 Oct;28(8):1569-1575

Gynecologic Oncology, Fondazione Policlinico A. Gemelli, IRCCS.

Background: Platinum-based chemotherapy plus bevacizumab is the new standard of care in stage IVB cervical cancer (CC) patients. In this new scenario, radical surgery could be offered in selected cases with an optimal clinical response. Potential surgical complications related to previous bevacizumab treatment have never been described before in this type of setting. Read More

J Obstet Gynaecol Res 2018 Dec 21;44(12):2186-2189. Epub 2018 Aug 21.

Department of Obstetrics and Gynecology, Mie University School of Medicine, Tsu, Japan.

A 52-year-old woman presented to our hospital complaining of genital bleeding and was found to have a 50-mm vaginal tumor that involved the bladder, rectum, and small bowel and extended to the left pelvic side wall. Her history included a bilateral salpingo-oophorectomy and a total abdominal hysterectomy for fibroids and endometriosis. She had been prescribed estrogen replacement therapy (1. Read More

Ann Plast Surg 2018 Nov;81(5):576-583

Gynecologic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.

Background: Several techniques for vaginal reconstruction after pelvic exenteration such as myocutaneous and myoperitoneal flaps are available. However, the use of a myofascial flap has not been previously described. Thus, the objective of this article is to present our experience of vaginal reconstruction with rectus abdominis myofascial (RAMF) flap. Read More

Hinyokika Kiyo 2018 Jul;64(7):307-311

The Department of Urology, Osaka General Medical Center.

We report two cases of clear cell adenocarcinoma arising in the urethral diverticulum. Case 1 occurred in a 79-year-old woman presenting with complaints of frequent micturition. Magnetic resonance imaging (MRI) revealed a localized urethral diverticular tumor. Read More

Eur J Surg Oncol 2018 10 20;44(10):1548-1554. Epub 2018 Jul 20.

Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Background: Total pelvic exenteration (TPE) is a radical approach for locally advanced rectal cancer (LARC) and locally recurrent rectal cancer (LRRC) in case of tumour invasion into the urogenitary tract. The aim of this study is to assess surgical and oncological outcomes of TPE for LARC and LRRC in elderly patients compared to younger patients.

Methods: All patients who underwent TPE for LARC and LRRC between January 1990 and March 2017 were retrospectively analyzed. Read More

Medicine (Baltimore) 2018 Jul;97(30):e11611

Department of Gynecology, Chongqing Medical University First Affiliated Hospital, Chongqing, China.

Rationale: Pelvic exenteration is considered a method to treat central recurrent or persistent gynecologic malignancy after the initial therapy. The postoperative survival rate has been greatly increased by the improvement in the surgical technology and the perioperative management. Yet various complications are still impacting the quality of life. Read More

Gan To Kagaku Ryoho 2018 Jun;45(6):973-975

Dept. of Surgery, Nagoya Ekisaikai Hospital.

A 66-year-old man was referred to our hospital after being diagnosed with a pelvic tumor. A subsequent transperineal biopsy revealed spindle cells with CD34·c-kit(+). An enhanced computed tomography scan showed a giant rectal-derived tumor in the pelvis. Read More

J Gynecol Oncol 2018 Sep 4;29(5):e68. Epub 2018 May 4.

Department of Gynecologic Oncology and Reproductive Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.

Objective: To determine the effect of surgeon experience on intraoperative, postoperative and long-term outcomes among patients undergoing pelvic exenteration for gynecologic cancer.

Methods: This was a retrospective analysis of all women who underwent exenteration for a gynecologic malignancy at MD Anderson Cancer Center, between January 1993 and June 2013. A logistic regression was used to model the relationship between surgeon experience (measured as the number of exenteration cases performed by the surgeon prior to a given exenteration) and operative outcomes and postoperative complications. Read More

Surg Endosc 2018 Dec 17;32(12):4707-4715. Epub 2018 Jul 17.

Background: Pelvic exenteration is potentially curative for locally advanced and recurrent pelvic cancers. Evolving technology has facilitated the use of minimally invasive surgical (MIS) techniques in selected cases. We aimed to compare outcomes between open and MIS pelvic exenteration. Read More

BMJ Case Rep 2018 Jul 11;2018. Epub 2018 Jul 11.

Department of Urology, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.

We report a case of rapidly growing sarcoma that resulted in mortality only 6 years after radiotherapy for low-grade prostate cancer.At the age of 69 years and a prostate-specific antigen (PSA) that had risen to 9.0 µg/L, transrectal ultrasound-guided biopsy of the prostate found a single core of Gleason 3+3 disease involving 4 mm of a 10 mm core. Read More

Gynecol Oncol Rep 2018 Aug 29;25:56-59. Epub 2018 May 29.

Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Chirurgie Cancérologique Gynécologique et du Sein, Paris, France.

After concomitant chemo-radiation therapy, 20 to 30% of advanced cervical cancers recur in irradiated territory. Pelvic exenteration remains a therapeutic option for selected patients. However, this procedure remains complex because of tissue fragility after radiotherapy and their associated co-morbidities. Read More

Colorectal Dis 2018 Dec 14;20(12):1070-1077. Epub 2018 Aug 14.

Department of Surgical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India.

Aim: Involvement of the anterior mesorectal fascia (iAMRF) after neoadjuvant treatment leads to either resection of the involved organ alone [extended resection of the rectum (ERR)] or total pelvic exenteration (TPE). The purpose of this study was to compare the rate of recurrence and survival of patients undergoing ERR or TPE for iAMRF after neoadjuvant treatment. The outcome of patients who underwent total mesorectal excision after downstaging was also compared. Read More

Gynecol Oncol 2018 08 28;150(2):389-390. Epub 2018 Jun 28.

Department of Surgical Oncology, Institut Claudius Regaud - Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France; INSERM CRCT Team 19, ONCOSARC - Oncogenesis of sarcomas, Toulouse, France. Electronic address:

Background: Improvements in surgical technique of pelvic exenteration have mainly occurred in the reconstructive phase of the procedure. Quality of life seems to be improved when performing continent rather than non-continent urinary diversion [1]. Unfortunately, Miami continent urinary pouch is a surgical technique not frequently used among surgeons. Read More

Psychooncology 2018 Oct 18;27(10):2357-2362. Epub 2018 Jul 18.

Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA.

Objective: Pelvic exenteration (PE) in carefully selected gynecologic cancer patients has a 5-year survival rate as high as 60%. Thus, there is a growing number of PE survivors dealing with the effects of this radical surgery. The current study sought to explore women's physical, psychological, and social quality of life (QOL) after PE. Read More

Chin Med J (Engl) 2018 Jul;131(13):1541-1548

Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.

Background: Pelvic exenteration (PE) for primary and recurrent cervical cancer has resulted in favorable survival outcomes, but there are controversies about specific prognosis factors, and up to now, there have been no published reports from China. This study aimed to share our experiences of PE, which were performed in a single institution.

Methods: From January 2009 to January 2016, 38 patients with recurrent or persistent cervical cancer were included in the study, and they were followed up until January 2017. Read More

Colorectal Dis 2018 Nov 16;20(11):1004-1013. Epub 2018 Jul 16.

Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

Aim: Pelvic exenteration surgery remains the only curative option for recurrent rectal cancer. Microscopically involved surgical margins (R1) are associated with a higher risk of local recurrence and decreased survival. Our study aimed to develop a post hoc multidisciplinary case conference review and investigate its potential for identifying areas for improvement. Read More

ANZ J Surg 2018 Sep 12;88(9):896-900. Epub 2018 Jun 12.

Department of Urology, Singapore General Hospital, Singapore.

Background: Pelvic exenteration (PE) for locally advanced pelvic malignancy requires a multi-disciplinary approach and is associated with significant morbidity. Urinary reconstruction forms a major component of this procedure. The aim of the study is to review the urological outcomes following PE in a newly established pelvic oncology unit, to compare with those following radical cystectomy (RC) for bladder cancer. Read More

Cureus 2018 Apr 10;10(4):e2457. Epub 2018 Apr 10.

Radiation Oncology, Princess Margaret Cancer Centre, Toronto / University of Toronto, Toronto, CAN.

Management options for locally recurrent sarcoma of the pelvis in patients previously treated with external beam radiation and surgery are limited. Pelvic exenteration is often the only viable but unattractive option. We present a patient with recurrent myxoid round cell liposarcoma of the ischiorectal fossa treated in 2013 with preoperative radiation (50 Gy in 25 fractions) and subsequent wide local resection. Read More

Surg Today 2018 Nov 1;48(11):978-985. Epub 2018 Jun 1.

Department of Colorectal Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

Purpose: Perineal wound infection (PWI) rates are high after abdominoperineal resection (APR) and total pelvic exenteration (TPE). This study identified risk factors for PWI after surgery for anorectal tumors and examined the relationship between the surgical excision volume with the PWI degree.

Methods: A retrospective review involving 135 patients who underwent surgical excision of anorectal tumors was performed. Read More